Switch theme
Sign up to access all valuation multiples
Kenvue is the world’s largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue’s brands are the global leader in their respective segment thanks to their strong brand power.
2022
22K+
LTM Revenue $15.4B
LTM EBITDA $3.7B
$51.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Kenvue has a last 12-month revenue of $15.4B and a last 12-month EBITDA of $3.7B.
In the most recent fiscal year, Kenvue achieved revenue of $15.5B and an EBITDA of $2.5B.
Kenvue expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Kenvue valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $15.4B | $15.5B | XXX | XXX | XXX |
| Gross Profit | $8.2B | $8.6B | XXX | XXX | XXX |
| Gross Margin | 53% | 56% | XXX | XXX | XXX |
| EBITDA | $3.2B | $2.5B | XXX | XXX | XXX |
| EBITDA Margin | 21% | 16% | XXX | XXX | XXX |
| Net Profit | $1.5B | $1.7B | XXX | XXX | XXX |
| Net Margin | 9% | 11% | XXX | XXX | XXX |
| Net Debt | $7.8B | $6.9B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of March 14, 2025, Kenvue's stock price is $23.
Kenvue has current market cap of $43.6B, and EV of $51.2B.
See Kenvue trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $51.2B | $43.6B | XXX | XXX | XXX | XXX | $1.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of March 14, 2025, Kenvue has market cap of $43.6B and EV of $51.2B.
Kenvue's trades at 3.3x LTM EV/Revenue multiple, and 14.0x LTM EBITDA.
Analysts estimate Kenvue's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Kenvue and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $51.2B | XXX | XXX | XXX |
| EV/Revenue | 3.3x | XXX | XXX | XXX |
| EV/EBITDA | 20.8x | XXX | XXX | XXX |
| P/E | 42.3x | XXX | XXX | XXX |
| P/E/Growth | 0.8x | XXX | XXX | XXX |
| EV/FCF | 38.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpKenvue's NTM/LTM revenue growth is 0%
Kenvue's revenue per employee for the last fiscal year averaged $0.7M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Kenvue's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Kenvue's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Kenvue and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -22% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 16% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.7M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 41% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kenvue acquired XXX companies to date.
Last acquisition by Kenvue was XXXXXXXX, XXXXX XXXXX XXXXXX . Kenvue acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Kenvue founded? | Kenvue was founded in 2022. |
| Where is Kenvue headquartered? | Kenvue is headquartered in United States of America. |
| How many employees does Kenvue have? | As of today, Kenvue has 22K+ employees. |
| Who is the CEO of Kenvue? | Kenvue's CEO is Mr. Thibaut Mongon. |
| Is Kenvue publicy listed? | Yes, Kenvue is a public company listed on NYS. |
| What is the stock symbol of Kenvue? | Kenvue trades under KVUE ticker. |
| When did Kenvue go public? | Kenvue went public in 2023. |
| Who are competitors of Kenvue? | Similar companies to Kenvue include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Kenvue? | Kenvue's current market cap is $43.6B |
| What is the current revenue of Kenvue? | Kenvue's last 12-month revenue is $15.4B. |
| What is the current EBITDA of Kenvue? | Kenvue's last 12-month EBITDA is $3.7B. |
| What is the current EV/Revenue multiple of Kenvue? | Current revenue multiple of Kenvue is 3.3x. |
| What is the current EV/EBITDA multiple of Kenvue? | Current EBITDA multiple of Kenvue is 14.0x. |
| What is the current revenue growth of Kenvue? | Kenvue revenue growth between 2023 and 2024 was 0%. |
| Is Kenvue profitable? | Yes, Kenvue is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
